NCT01703442

Brief Summary

A single-center prospective observational study. This study examines urine flow and haemodynamic parameters during abdominal surgery and analyses the association to postoperative renal function and markers and to postoperative clinical outcome. Primary hypothesis:

  • Within a goal-directed haemodynamic protocol during gynecologic cancer surgery there are phases of temporary anuria. Secondary hypothesis:
  • Perioperative anuric phases are directly associated to the postoperative increase of NGAL (neutrophil gelatinase-associated lipocalin) and creatinine
  • Perioperative renal dysfunction is directly associated to postoperative complications and functional recovery of patients
  • A response of urine flow to a standardized postoperative diuretic bolus can identify patients who benefit from a pharmaceutical fluid mobilization
  • Within a goal-directed haemodynamic protocol during gynaecologic cancer surgery, the methods for the measurement of stroke volume of the heart differ

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2016

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 24, 2012

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 10, 2012

Completed
3.8 years until next milestone

Study Start

First participant enrolled

August 1, 2016

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

August 11, 2016

Status Verified

August 1, 2016

Enrollment Period

1.8 years

First QC Date

September 24, 2012

Last Update Submit

August 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Exact measurement of urine production

    Exact measurement of urine production (number of anuric episodes anf duration of anuric episodes in minutes)

    During the operation and in the 72-hour postoperative sample period

Secondary Outcomes (13)

  • Exact measurement of urine production

    During the operation and in the 72-hour postoperative sample period

  • Biomarker for renal injury, Neutrophil gelatinase-associated lipocalin (NGAL) and creatinine

    During the operation and in the 72-hour postoperative sample period

  • Hemodynamic parameters

    During the operation

  • Blood loss

    During the operation

  • Depth of Anesthesia

    During the operation

  • +8 more secondary outcomes

Study Arms (1)

Ovarian cancer patients

Perioperative primary epithelial ovarian cancer patients

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female patients being treated in the Department of Gynecology and Obstetrics, Campus Virchow Klinikum, Charité - Universitaetsmedizin Berlin.

You may qualify if:

  • Offered patient information and written informed consent
  • Female patients aged greater than or equal to 18 years for cytoreductive surgery of a primary epithelial ovarian tumour

You may not qualify if:

  • Patients with relapse Ovarian Cancer
  • Patients aged less than 18 years
  • Persons without the capacity to consent
  • Unability of German language use
  • Lacking willingness to save and hand out data within the study
  • Accommodation in an institution due to an official or judicial order
  • (Unclear) history of alcohol or substances disabuse
  • Coworker of the Charité
  • Advanced disease of the oesophagus or upper respiratory tract at the beginning of hospitalisation
  • Operation in the area of the oesophagus or nasopharynx within the last two months before participation in the study
  • Neurological or psychiatric disease at the beginning of hospitalisation
  • CHF (congestive heart failure) according to (New York Heart Association) classification - NYHA class IV at the beginning of hospitalisation
  • American Society of Anaesthesiologists (ASA) classification greater than IV
  • Renal insufficiency (dependency of haemodialysis) at the beginning of hospitalisation
  • Pulmonal oedema in thorax x-ray at the beginning of hospitalisation
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Intensive Care Medicine, Campus Virchow Klinikum, Charité - Universitaetsmedizin

Berlin, State of Berlin, 13353, Germany

Location

Study Officials

  • Claudia Spies, MD, Prof.

    Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charité - University Berlin

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Anesthesiology and Intensive Care Medicine CVK/CCM, Charite University, Berlin, Germany

Study Record Dates

First Submitted

September 24, 2012

First Posted

October 10, 2012

Study Start

August 1, 2016

Primary Completion

June 1, 2018

Study Completion

September 1, 2018

Last Updated

August 11, 2016

Record last verified: 2016-08

Locations